Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
for Recurrent Adenoid Cystic Carcinoma
Sponsor: National Cancer Centre, Singapore
Sex: All·Age: 18 - 99
Code: NCT07521670·Phase 2·Not Yet Recruiting·Listed Apr 2026